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Abstract: Site-directed mutagenesis is a traditional approach for structure-function analysis of
protein tyrosine kinases, and it requires the generation, expression, purification, and analysis of
each mutant enzyme. In this study, we report a versatile high throughput bacterial screening
system that can identify functional kinase mutants by immunological detection of tyrosine
phosphorylation. Two key features of this screening system are noteworthy. First, instead of
blotting bacterial colonies directly from Agar plates to nitrocellulose membrane, the colonies
were cultured in 96-well plates, and then spotted in duplicate onto the membrane with
appropriate controls. This made the screening much more reliable compared to direct colony
blotting transfer. A second feature is the parallel use of a protein tyrosine phosphatase (PTP)expressing host and a non-PTP-expressing host. Because high activity Src mutants are toxic to
the host, the PTP system allowed the identification of Src mutants with high activity, while the
non-PTP system identified Src mutants with low activity. This approach was applied to Src
mutant libraries randomized in the highly conserved HRD motif in the catalytic loop, and
revealed that structurally diverse residues can replace the His and Arg residues, while the Asp
residue is irreplaceable for catalytic activity.
Keywords: Src protein tyrosine kinase, catalytic loop, HRD motif, bacterial colony screening.
Impact statement: Protein tyrosine kinases are a large family of regulatory enzymes associated
with cancer development. Structural variations among protein tyrosine kinases determine their
function and regulation in the cells. Identifying structure-function relationships is essential for
understanding their catalytic and regulatory mechanisms and for drug development. This study
presents a versatile approach for identifying functional mutants of protein tyrosine kinase, in the
effort to establish protein tyrosine kinase structure-function relationships.
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1.

Introduction
Protein tyrosine kinases (PTKs)1 are important signaling proteins and anticancer drug

targets[1, 2]. A full understanding of their biological roles in normal and pathological conditions,
and rational inhibitor design require an understanding of the structural basis of PTK catalysis,
regulation, and substrate specificity. The catalytic domains of PTKs are generally similar,
sharing many residues essential for structural integrity, catalysis, and regulation [3, 4].
Elucidating the roles of evolutionarily conserved as well as variable residues in PTK catalysis,
regulation or structural integrity requires extensive research using multidisciplinary tools, such as
biochemistry, structural biology and biophysics.
One useful tool for this research is site-directed mutagenesis and heterologous
expression. A residue in a kinase can be replaced by any other standard amino acid residue and
the mutant enzyme can often be readily expressed in an appropriate bacterial host. Upon
purification of a mutant enzyme, it can be characterized to determine the effects of the mutation.
The challenge with this approach is that it is time-consuming because each mutant needs to be
expressed, purified and characterized. Considering that each residue could require up to 19
mutants for a full analysis, the challenge grows exponentially with the addition of each residue to
analyze. Furthermore, when a mutant has no catalytic activity, the effect of the mutation
becomes difficult to characterize. It would therefore be desirable to develop a convenient and
high throughput screening system in bacteria to identify active PTK variants from a library of
mutants.
There are several challenges in developing this approach. First, while some PTKs can be
readily expressed in bacteria, others are toxic to the bacterial host [5, 6]. This toxicity is due to
the phosphorylation of bacterial proteins by the heterologous PTK, but can be overcome by the
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co-expression of a protein tyrosine phosphatase (PTP) [6-9]. Second, expression of PTKs in a
bacterial host is often plagued by other generic issues, such as differences in codon usage
between higher organisms and bacteria, protein folding and solubility [10]. Solutions to each of
these problems have been developed. Plasmids that express tRNAs rarely used in bacteria can
help alleviate the codon usage problem [11, 12], while co-expression of chaperones, such as
GroES/EL can help heterologous PTK fold more efficiently [13-16].
In this study, we developed a bacterially based rapid high throughput screening method that
incorporates each of these elements. We validate this system by using it to study the functionality
of the HRD motif in the protein tyrosine kinase Src. The HRD motif is the first three residues in
the highly conserved catalytic loop of protein kinases [17]. In Src, The HRD motif is three
residues 384-386. Asp386 of this motif is the catalytic base, and is considered indispensable for
catalysis [18-22]. His384 and Arg385 have been thought to be key regulatory residues as their
interactions vary in different activity states of several kinases [20, 23-28]; however their exact
roles in PTK regulation have not been fully defined. This study confirms that the Asp386 residue
is indeed essential for catalysis as previously demonstrated, while the His384 and Arg385 can be
replaced by a wide variety of residues without abolishing kinase activity.

2.

Results

2.1.

Bacterial proteins are phosphorylated on tyrosine residues when PTKs are

heterologously expressed in E coli. For screening of active PTKs or mutants in bacteria, it would
be desirable if the kinases phosphorylate bacterial proteins that can be detected by Western
blotting using anti-phosphotyrosine antibodies. It will then spare the need to express a specific
substrate for the kinase in the bacterial cells. To confirm that eukaryotic PTKs phosphorylate
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bacterial proteins, four protein tyrosine kinases, Abl, Csk, FGFR1, and Lck were each cloned
into pGEX-4T-1 and the plasmids were introduced into E. coli DH5α (hereafter called E. coli).
Fig. 1A shows a Western blot detecting protein tyrosine phosphorylation after the bacteria were
cultured in LB medium at 370C for 24 hours. E. coli cells containing the empty expression
vector did not produce any detectable protein tyrosine phosphorylation (Fig 1A, lane 1).
Expression of each PTK resulted in significant tyrosine phosphorylation of proteins of various
sizes. Even with FGFR1, which resulted in relatively low levels of protein phosphorylation, it
was still readily detectable.

2.2.

Active Src expression in E. coli requires the co-expression of a protein tyrosine

phosphatase. Fully active Src is toxic to E. coli and cannot be expressed unless it is coexpressed with a PTP [6-9]. While the co-expression of a PTP helps reduce the toxicity
associated with PTK expression, the PTP might reduce the phosphorylation of bacterial proteins
to a level that is undetectable by Western blotting. That would preclude phosphotyrosine-based
screening. We therefore examined whether phosphotyrosine can still be detected in E. coli when
active Src is co-expressed with a PTP. The wtSrc, kinase-defective Src (kdSrc, containing a
Lys295Met mutation) [13, 14] and truncated Src (SD-Src: His384 was replaced with Ser, and
Arg385 replaced with a stop codon) in the pRSET-a plasmid were introduced into E. coli
BL21(DE3)RIL harboring the pREP4groESL and pCDF-PTP1B plasmids. The truncated Src
mutant, SD-Src, was included here because it will be used as a parental plasmid for generating
Src mutant libraries in later experiments. By mutating the HR residues in the HRD motif to S
we achieved two purposes: the mutation completely eliminated Src kinase activity and generated
a restriction site (AGTACT for Sca I) on the plasmid. Using SD-Src as a parental plasmid for
5
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library generation eliminates parental plasmids as false positives in the library screening.
Incorporating a restriction site allows convenient mutation verification.
Individual colonies were grown for 24 h at 370C in LB broth. Soluble fractions from the
cultured cells were analyzed by Western blotting using monoclonal antibodies specific for
phosphotyrosine or phosphotyrosine 416 of Src, which is the site of Src autophosphorylation
[29]. The active wtSrc phosphorylated bacterial proteins and Src itself on Tyr416, whereas
neither kdSrc nor SD-Src resulted in detectable phosphorylation (Fig. 1B). The presence of the
PTP significantly reduced the number of proteins phosphorylated on tyrosine compared to those
by other kinases without the PTP (Fig. 1A and 1B). Even in the presence of the PTP, however,
the residual phosphotyrosine level was still sufficient for Western blot detection when wtSrc was
expressed.
Co-expression of a PTP poses a dilemma for phosphotyrosine-based screening to identify
active Src mutants. While the expression of wtSrc and Src mutants with high activity requires a
PTP, co-expression of a PTP may reduce the phosphotyrosine signal to a point as to prevent
identification of mutants with low activity. As previously demonstrated, low activity Src mutants
can be expressed in bacteria without the help of a PTP [6]. With the opposing requirements by
low activity and high activity Src mutants, we introduced each Src mutant library into E. coli coexpressing the PTP 1B (the PTP system) and E. coli not co-expressing PTP 1B (the non-PTP
system) for dot blot screening. We anticipated that the more active mutants would likely be
selected in the PTP system and the less active mutants would likely be selected in the non-PTP
system.

2.3.

Dot blot screening. We explored the dot blotting format to make the screening more high
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throughput. There are two general ways of transferring colonies onto a nitrocellulose membrane
for screening: blotting colonies from an Agar plate onto the membrane directly, or culturing the
colonies in liquid and dot blotting the cultures on to the membrane. While the former is more
direct and convenient, it did not work well in our hands. Both the colony size and the blotting
transfer efficiency from the plate to the membrane varied from colony to colony, resulting in low
reproducibility. The second approach worked much better and is outlined in Fig. 2B. It involves
inoculating colonies for overnight individual liquid cultures in 96-well plates, and spotting a
similar number of cells on the membrane. Positive controls (cells expressing an active kinase)
and negative controls (cells that do not express an active kinase) can be spotted on the
membrane, and each can be spotted in duplicate. Using this approach, the detection signals from
the positive and negative controls consistently reflected the kinase activity expressed.
We tested this screening strategy on Src by determining the residues that can functionally
replace the HRD motif. The HRD motif is the first three residues (His384-Arg385-Asp386 in
Src) in the catalytic loop. Asp386 in Src (or its equivalent in other kinases) is the catalytic base
[22, 30] in catalyzing the phosphoryl transfer reaction. As such, this Asp residue is thought to be
essential for catalysis, but it is not clear if any other residue can functionally replace it. His384
and Arg385 are thought to be important regulatory residues [28, 31], even though the specific
roles they play in regulation are not clear. It has been shown that His384 in Src can be replaced
by several residues and still maintain some level of kinase activity [6]. Mutation of Arg385 to
Ala results in low kinase activity in v-Src [32], while an Arg to Cys mutation has little effect on
the kinase activity of Drosophila Src64 [33]. Considering the ambiguous requirements for these
residues, we thought a thorough evaluation of these positions may be informative, and
identifying functional HRD mutants of Src would be a good test for the screening system.
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To apply the high-throughput screening to the HRD motif in Src, we first generated a
truncated form of Src, SD-Src, in which Ser replaced His384 and a stop codon replaced
Arg385. With this truncation in the HRD motif, SD-Src loses approximately half of the
catalytic domain, and all its catalytic activity. The mutant libraries are generated by mutating the
codons for SD into appropriate codons required for each mutant library, as explained in the
following sections. The reason we used SD-Src, instead of wtSrc, as the parental plasmid is that
because SD-Src is catalytically truncated and thus not active, any unmutated parental plasmid
will not result in a false positive colony during screening. Otherwise, the false positives from
unmutated original plasmids would outnumber the active mutants from the mutation library.

2.4.

Identification of residues that can replace His384 in the HRD motif. A His384 mutation

library was created by mutating the S codons in SD-Src to the codons for XRD, where X is
the randomized residue, while R restored the wt Arg residue at the 385 position. The randomized
plasmids were introduced into both the non-PTP system and the PTP system, and the colonies
were subjected to the screen outlined in Fig. 2B. Representative screening results from the PTP
system and non-PTP system, respectively, are shown in Fig. 3. As shown in the blots, the
positive controls (wtSrc) consistently produced positive signals while the negative controls
(kdSrc and SD-Src) consistently produced undetectable signals. When a box containing a
colony from the mutant library produced two visible signals, the mutant was considered a
positive. The colonies were then cultured and the plasmids from the positive colonies were
isolated and sequenced to identify the mutations.
Approximately 630 random colonies were screened in the PTP system (Fig. 3A), and five
positives were identified. All five mutants had histidine at the 384 position, with both CAT and
8
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CAC codons used. This result indicated that only wild type Src with a His at this position
generated sufficient tyrosine phosphorylation signal to be selected as a positive in the PTP
system. In the non-PTP system, ~20 mutants on average were positives for each 96-slot
screening (Fig. 3B). Fifty random positives were selected and their plasmids were sequenced.
Nine different mutants, His384Gln, His384Tyr, His384Thr, His384Ser, His384Phe, His384Leu,
His384Val, His385Ile and His384Gly, were identified. Wild type Src was not identified from the
non-PTP system, presumably because wtSrc is toxic to E. coli without a PTP.
To confirm the catalytic activity of the His384 mutants, all nine mutant enzymes were
expressed and purified. The relative kinase activity of these mutants was determined using
polyE4Y as a substrate (Fig. 4). All mutants maintained active kinase activity and His385Gln had
the highest catalytic activity at ~14% of that of the wild type. The functional substitutions for
His384 were either hydrophobic residues, Phe (10.2%), Leu (1.1%), Val (0.6%) I (0.6%) and Gly
(0.2%), or polar but not charged residues, Gln (14.2%), Tyr (6.2%), Thr (6.0%) and Ser (2.6%).
This result supports the proposal that His384 is involved in hydrophobic interactions in
stabilizing the active conformation [25], and also suggests that His384 may interact with other
residues through hydrogen bonds in some conformations.

2.5.

Identification of residues that can replace Arg385 in the HRD motif. We next applied this

strategy to Arg385 by replacing S codons in SD-Src with codons for HX, where H restores
the His384 and X is randomized residue at the 385 position. Representative screening results
using the PTP and non-PTP systems are shown in Fig. 5. In both expression systems, a large
number of positive colonies were identified. Approximately 50 functional mutants were selected
and sequenced from each screening system. While each system produced its own unique
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variants, some mutants were found in both systems. Arg385Gln and Arg385Tyr were selected
only from the non-PTP system, while Arg385Lys, Arg385Val, Arg385Asn, Arg385Leu,
Arg385Cys and wtSrc were only found in the PTP system. Arg385Ala, Arg385Gly, Arg385Ser,
and Arg385Thr were selected from both systems. These results suggested that a variety of
Arg385 mutants maintained significant catalytic activity.
Selected mutants from both systems were purified and the catalytic activity was
determined (Fig. 6). As expected, many mutants displayed significant kinase activity, with some
approaching that of wtSrc. It is remarkable that Val, Asn and Cys, with side chains very different
from each other and from that of Arg, can all replace Arg385 and maintain most of the kinase
activity. No negatively charged residue was identified at this position from either system.

2.6.

The PTP system and non-PTP system can each accommodate Src mutants with kinase

activities within a defined range. An examination of the results of all of the above screening
suggests that the PTP system and the non-PTP system can each accommodate Src mutants with a
broad range of kinase activities. The 9 mutants selected from the PTP system had kinase
activities ranging from ~17.2 (Arg385Ser) to 88.3% (Arg385Asn). Because wtSrc was also
selected from the PTP system, this result indicated that the range of kinase activity that can be
selected by the PTP system is ~17% to 100% of the wtSrc activity. Mutants with activities below
17% were likely unable to produce a positive signal due to the PTP dephosphorylation. Among
the 13 mutants identified from the non-PTP system, including 9 His384 mutants and 4 Arg385
mutants, Arg385Thr had the highest activity at 30.8%, while His384Gly had the lowest activity
at 0.2%, indicating that the selective range for the non-PTP system was 0.2% to 31% of the wild
type activity. The upper limit is likely determined by the threshold of kinase toxicity that can be
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tolerated by the bacterial host cells.

2.7.

Identification of residues that can replace Asp386 in the HRD motif. The same approach

was applied to identify residues that can replace Asp386 in the HRD motif. In generating the
Asp386 mutants, the codons for SD in SD-Src were replaced with the codons for HRX. The
HR codons restored the wildtype His and Arg residues at 384 and 385 positions, while the X
represented the randomized codon for the 386 position. The library was screened in the PTP and
non-PTP systems, and typical results are shown in Fig. 7. A total of 630 colonies were screened
in each screening system. Only the PTP system produced positive colonies, and sequencing
indicated that all the positive colonies contained wtSrc, with Asp386 being coded by either GAT
or GAC codons. With 630 colonies screened in each system, the probability of any of the 64
codons not being represented among these colonies in each of the systems is about 0.3%. This
result indicated that replacing Asp386 by any other residue could not retain even 0.2% of wtSrc
kinase activity, the lower limit of the non-PTP system. This result supports the assignment of
Asp386 as an indispensable residue for Src catalysis [20].

3.

Discussion
We report a bacterially based high throughput screening method for identifying

functional PTK mutants. This method incorporates all the tools that have been developed to help
protein kinase expression in bacteria, including expressing rarely used tRNAs in bacteria, coexpressing a chaperone to help the target PTK fold, and co-expression of a protein tyrosine
phosphatase to help overcome toxicity associated with the expression of some PTKs. While the
co-expression of a PTP helps with the expression of a toxic PTK, its inclusion in the screening
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system results in a bias that favors high activity mutants and prevents the identification of low
activity mutants. Using parallel PTP and non-PTP systems removes the bias, and enables the
identification of mutants with all levels of activity. While such a system may not be necessary
for all PTKs, it is particularly useful for a toxic PTK, such as Src. Using several small Src mutant
libraries randomizing the highly conserved HRD motif, the benefits of the parallel PTP and nonPTP systems became obvious, as each system selected Src mutants with kinase activities that fall
within a broad range.
Another important feature of the screening system is how the colonies from Agar plates
are transferred to a nitrocellulose membrane. Instead of transferring the colonies by directly
blotting the colonies from the plates to the membrane, each colony was cultured in 96 well
plates, and comparable number of cells were then dot-blotted onto the filter paper. This
eliminated the variation in colony size, uneven colony blotting, and also enabled duplication of
colonies and incorporation of positive and negative controls in the screening. Despite the extra
step that may limit the number of colonies that can be conveniently screened, this approach is
superior for most applications. A previous report described colony screening to identify
substrates for a given kinase [34]. In this earlier study, no PTP and chaperones were used. While
this method served the purposes of the previous study, the incorporation of the PTP and
chaperone is necessary to eliminate the bias caused by toxic PTKs. A comparison between the
results from the PTP and non-PTP systems indicates that the non-PTP system has an inherent
bias that would have precluded the identification of the high activity Src mutants.
The screening method was successfully used to identify mutants in the HRD motif of Src
protein tyrosine kinase. The HRD motif is a highly conserved structural feature in PTKs, and
among protein kinases in general. It is well established that the Asp386 in the HRD motif is the
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catalytic base [20, 22]. Consistent with this designation is the extreme conservation at this
position in the kinome. Among 447 active protein kinases encoded by the human genome, only
one contains a non-Asp residue, a Ser in IRAK3, at this position[4]. In contrast, among 50
human pseudokinases, 33 contain a residue other than Asp at the equivalent position. Therefore,
missing the Asp residue is considered a hallmark of pseudokinases, even though some
pseudokinases were discovered to possess significant kinase catalytic activity [35-38]. Whether
Asp can be replaced by any other residue has not been fully tested in any kinase. The screening
of an Asp386 mutant library indicated that no other residue was able to replace Asp386 to allow
significant kinase activity in Src (> 0.2% of wild type).
The roles His384 and Arg385 play in the kinase function are less understood. There are
considerable variations at these positions even though there is a general conservation in the
kinome. Among 447 active kinases encoded by the human genome, 52 (12%) contain a non-His
residue at the position equivalent to His384, including Tyr (44/52), Leu (5/52), Cys (1/52), Phe
(1/52), and Ile (1/5Most of these residues (except Cys) were also identified in our His384 mutant
library (Fig. 4). Loss of His at this position is not a defining feature of pseudokinases, as 80% of
pseudokinases retain a His at this position (compared to 88% among active kinases).
Furthermore, most of the same residues used by active kinases are also used by pseudokinases.
Approximately 83% of the 447 active human protein kinases and only 40% pseudokinase contain
an Arg residue at the position equivalent to Arg385, suggesting that the Arg residue at this
position is important for the kinase function. Among the 75 protein kinases using a non-Arg
residue at this position, the top six substitutions are Leu (19/75), Gly (15/75), Cys (9/75), Ala
(7/75), Thr (5/75) and Lys (5/75). All of these residues could indeed replace Arg to afford Src
kinase activity in the Arg385 library (Fig. 6). Among the 50 pseudokinases, 20 have an Arg, 18
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have a Gly, and a small number used Lys (4), Cys (2) among others. Because the similar sets of
residues are used by the active kinases and peudokinases, the residue at this position does not
define an active or inactive kinase. It is interesting to note that negatively charged residues, Asp
or Glu, do not appear at the positions equivalent to H384 or R385 in any active or inactive
human kinases, and were not selected in the H384 and R385 libraries. A question remains
unanswered as to why His and Arg are conserved through evolution although they are not
required in most kinases. It is plausible that conservation is based on certain non-catalytic
functions unique to some kinases, such as regulation. Protein kinases in different families often
have unique regulatory mechanisms, yet all the mechanisms are based on a common
conformational elasticity embedded in the kinase catalytic domain [39-43]. Further studies will
be needed to determine whether the HRD motif is involved in controlling conformational
changes underlying kinase regulation.

4. Materials and Methods
4.1.

Reagents and chemicals. Consumables, culture media, and media components were

purchased from Fisher Scientific. The QuikChange mutagenesis kit was purchased from
Stratagene. Specific antibodies were purchased from Cell Signaling Technology. DNA primers
were synthesized by Integrated DNA Technologies. The chromatographic resin, Ni-NTA
agarose, was purchased from Qiagen. Bradford reagent and pre-cast SDS-PAGE gels were
purchased from Bio-Rad. All the other chemicals were purchased from Sigma.

4.2.

Construction of PTK expression plasmids. Wild type human Abl catalytic domain [44],

full-length Csk [14], FGFR1 catalytic domain [45], and full-length Lck [5] were cloned into
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pGEX-4T-1 plasmid using BamHI and EcoRI restriction sites as described previously and
expressed in Escherichia coli DH5α. All constructs were verified by sequence analysis. Plasmids
were introduced into the specific expression systems by electroporation.

4.3.

Molecular construction of Src and Src mutants and their expression in a PTP system and

a non-PTP system. Wild type Src was cloned into the pRSETA plasmid using Bam HI and
HindIII restriction sites as described previously [6, 13, 14]. Kinase-defective Src (kdSrc,
containing a Lys295Met mutation) [13] and truncated Src (S-Src: His384 was replaced with
Ser, and Arg385 replaced with a stop codon) were generated by QuikChange site-directed
mutagenesis. Active Src and Src mutants were expressed in a PTP system (BL21(DE3)RIL
harboring the pREP4groESL and pCDF-PTP1B plasmid) [13] and a non-PTP system
(BL21(DE3)RIL harboring the pREP4groESL) [6] for screening purposes.

4.4.

Mutant library construction and active mutant screening. A QuikChange mutagenesis kit

was used for the construction of mutant libraries. The plasmid pRSETA S-Src was used as
template for the construction of mutant plasmids to avoid wild type Src plasmid contamination in
constructed libraries. The primers for the His384 mutant library were 5’GGATGAACTACGTGXXXCGAGACCTGCGGGCGG and its complimentary primer. These
primers changed the His CAC codon to a random sequence (XXX) while keeping all other
neighboring residues as wildtype. The primers for the Arg385 mutant library were, 5’GGATGAACTACGTGCACXXXGACCTGCGGGCGGCC and its complimentary primer.
These primers changed the Arg CGA codon to a random sequence (XXX) while keeping all
other neighboring residues as wildtype.
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The primers for the Asp386 mutant library were 5’GGATGAACTACGTGCACCGAXXXCTGCGGGCGGCCAAC and its complimentary primer.
These primers changed the Asp GAC codon to a random sequence (XXX) while keeping all
other neighboring residues as wildtype.
QuikChange was performed as instructed by the manufacturer. The constructed mutant
plasmids were transformed into a PTP-system (BL21(DE3)RIL harboring the pREP4groESL and
pCDF-PTP1B plasmids) and a non-PTP system (BL21(DE3)RIL harboring the pREP4groESL).
Mutant colonies were inoculated into 96-well plates containing 200 l in LB broth in each well
with appropriate antibiotics. The plates were incubated for 24 h at 370C shaking at 250 rpm.
Then two 0.4 µl samples from each well (representing approximately 8x105 cells) were blotted
directly onto a nitrocellulose membrane. The membrane was heated at 950C for 5 min to lyse the
cells and blocked with milk. This was followed by immunoblotting using a mouse monoclonal
antibody against phosphotyrosine (PY100; Cell Signaling Technology) and an anti-mouse
secondary antibody conjugated to horseradish peroxidase (HRP) (Stratagene).

4.5.

Expression and purification of Src and active Src mutants. As described above, wild type

Src and active Src mutants were expressed in Escherichia coli BL21(DE3)RIL cells harboring
the pREP4groESL plasmid and pCDF-PTP1B by the use of the pRSETA plasmid as described
[6]. The plasmid pREP4groESL contains the genes for the GroES/EL chaperone, which helps
Src fold correctly [13]. The pCDF-PTP1B directs the expression of PTP1B, which keeps Src and
bacterial proteins dephosphorylated and reduces the toxicity of Src expression to bacterial cells
[7]. The (His)6-tagged active Src constructs were purified using immobilized Ni-iminodiacetic
acid-agarose as described previously [46]. Briefly, individual colonies were inoculated into 500
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mL of LB culture medium containing appropriate antibiotics. The cultures were grown to an
OD600 of 2.5 and diluted with 500 mL of fresh LB containing the antibiotics. The cultures were
air-cooled to room temperature, and 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG)
was added to induce the production of the fusion protein. Cultures were allowed to induce for 6 h
at room temperature with shaking at 250 rpm. Bacterial cultures were harvested by centrifugation
at 4,500g and stored at -20 °C before use. Cell pellets were resuspended with ice-cold lysis
buffer [50 mM Hepes (pH 8.0), 200 mM NaCl, 10 mM imidazole, and 0.1% Triton-X]. Cells
were lysed by French press and clarified by centrifugation at 47,800g for 30 min at 4 °C. The
supernatant was added to 0.75 mL of Ni-NTA agarose (Qiagen) and gently mixed by rotation at
4 °C for 30 min. The beads were loaded into a column and then washed with washing buffer (50
mM Hepes, pH 8.0, and 20 mM imidazole). Proteins were eluted by using 100–300 mM
imidazole in 50 mM Hepes (pH 8.0). Enzymes were desalted and stored in 50 mM Hepes (pH
8.0) at -20 °C in 40% glycerol. Protein concentration was determined by Bradford reagent
standardized with BSA (0.2–1.0 mg/ml). Purity of protein fractions was determined by
SDS/PAGE (Bio-Rad) and stained with Coomassie blue.

4.6.

Kinase assay. The kinase activity of wild type Src and Src mutants was determined by a

luminescent ADP detection assay (ADP-GloTM Kinase Assay, Promega) using polyE4Y and ATP
as substrates. The phosphorylation reactions were performed in 50 l volumes at 25oC in the
protein kinase assay buffer: 50 mM N-(2-hydroxyethyl)piperazine-N′-3-propanesulfonic acid (pH
8.0) containing 5% glycerol, 0.005% Triton X-100, and 0.05% 2-mercaptoethanol. The standard
assay used 12 mM MgCl2, 0.2 mM ATP, and 1 mg/ml polyE4Y. After a 30 min incubation, 5 l
of the kinase reaction mixture was mixed with 5 l ADP-GloTM reagent and incubated for 40 min
17
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to stop the kinase reaction and deplete the unconsumed ATP. Kinase detection reagent (10 l)
was added and the mixture was incubated for another 30 min to convert produced ADP to ATP
and introduce luciferase and luciferin to detect converted ATP. Then the luminescence produced
was measured by a plate-reading luminometer. Assays were performed in duplicate, and each
assay was repeated three times with reproducible results.

5. Acknowledgement
The authors have no conflict of interest in relation to this manuscript.

6.

References

1.

Blume-Jensen, P. and T. Hunter, Oncogenic kinase signalling. Nature, 2001. 411(6835):
p. 355-65.

2.

Capdeville, R., et al., Glivec (STI571, imatinib), a rationally developed, targeted
anticancer drug. Nat Rev Drug Discov, 2002. 1(7): p. 493-502.

3.

Hubbard, S.R. and J.H. Till, Protein tyrosine kinase structure and function. Annu Rev
Biochem, 2000. 69: p. 373-98.

4.

Manning, G., et al., The protein kinase complement of the human genome. Science, 2002.
298(5600): p. 1912-34.

5.

Sun, G. and R.J. Budde, A modified pGEX expression system that eliminates degradation
products and thrombin from the recombinant protein. Anal Biochem, 1995. 231(2): p.
458-60.

6.

Kemble, D.J., Y.H. Wang, and G. Sun, Bacterial expression and characterization of
catalytic loop mutants of SRC protein tyrosine kinase. Biochemistry, 2006. 45(49): p.

18
John Wiley & Sons

Page 18 of 35

Page 19 of 35

Protein Science

14749-54.
7.

Seeliger, M.A., et al., High yield bacterial expression of active c-Abl and c-Src tyrosine
kinases. Protein Sci, 2005. 14(12): p. 3135-9.

8.

Wang, W., et al., Structural characterization of autoinhibited c-Met kinase produced by
coexpression in bacteria with phosphatase. Proc Natl Acad Sci U S A, 2006. 103(10): p.
3563-8.

9.

Wang, Y.H., et al., A new strategy to produce active human Src from bacteria for
biochemical study of its regulation. Biochem Biophys Res Commun, 2006. 346(2): p.
606-11.

10.

Rosano, G.L. and E.A. Ceccarelli, Recombinant protein expression in Escherichia coli:
advances and challenges. Front Microbiol, 2014. 5: p. 172.

11.

Kleber-Janke, T. and W.M. Becker, Use of modified BL21(DE3) Escherichia coli cells
for high-level expression of recombinant peanut allergens affected by poor codon usage.
Protein Expr Purif, 2000. 19(3): p. 419-24.

12.

Rosano, G.L. and E.A. Ceccarelli, Rare codon content affects the solubility of
recombinant proteins in a codon bias-adjusted Escherichia coli strain. Microb Cell Fact,
2009. 8: p. 41.

13.

Wang, D., X.Y. Huang, and P.A. Cole, Molecular determinants for Csk-catalyzed
tyrosine phosphorylation of the Src tail. Biochemistry, 2001. 40(7): p. 2004-10.

14.

Lee, S., et al., Determination of the substrate-docking site of protein tyrosine kinase Cterminal Src kinase. Proc Natl Acad Sci U S A, 2003. 100(25): p. 14707-12.

15.

Amrein, K.E., et al., Purification and characterization of recombinant human p50csk
protein-tyrosine kinase from an Escherichia coli expression system overproducing the

19
John Wiley & Sons

Protein Science

bacterial chaperones GroES and GroEL. Proc Natl Acad Sci U S A, 1995. 92(4): p.
1048-52.
16.

Caspers, P., M. Stieger, and P. Burn, Overproduction of bacterial chaperones improves
the solubility of recombinant protein tyrosine kinases in Escherichia coli. Cell Mol Biol
(Noisy-le-grand), 1994. 40(5): p. 635-44.

17.

Hanks, S.K., A.M. Quinn, and T. Hunter, The protein kinase family: conserved features
and deduced phylogeny of the catalytic domains. Science, 1988. 241(4861): p. 42-52.

18.

Gibbs, C.S. and M.J. Zoller, Rational scanning mutagenesis of a protein kinase identifies
functional regions involved in catalysis and substrate interactions. J Biol Chem, 1991.
266(14): p. 8923-31.

19.

Skamnaki, V.T., et al., Catalytic mechanism of phosphorylase kinase probed by
mutational studies. Biochemistry, 1999. 38(44): p. 14718-30.

20.

Xu, W., et al., Crystal structures of c-Src reveal features of its autoinhibitory mechanism.
Mol Cell, 1999. 3(5): p. 629-38.

21.

Ablooglu, A.J., et al., Probing the catalytic mechanism of the insulin receptor kinase with
a tetrafluorotyrosine-containing peptide substrate. J Biol Chem, 2000. 275(39): p.
30394-8.

22.

Cole, P.A., et al., The role of the catalytic base in the protein tyrosine kinase Csk. J Biol
Chem, 1995. 270(38): p. 22105-8.

23.

Xu, W., S.C. Harrison, and M.J. Eck, Three-dimensional structure of the tyrosine kinase
c-Src. Nature, 1997. 385(6617): p. 595-602.

24.

Yamaguchi, H. and W.A. Hendrickson, Structural basis for activation of human
lymphocyte kinase Lck upon tyrosine phosphorylation. Nature, 1996. 384(6608): p. 484-

20
John Wiley & Sons

Page 20 of 35

Page 21 of 35

Protein Science

9.
25.

Kornev, A.P., et al., Surface comparison of active and inactive protein kinases identifies
a conserved activation mechanism. Proc Natl Acad Sci U S A, 2006. 103(47): p. 177838.

26.

Kornev, A.P., S.S. Taylor, and L.F. Ten Eyck, A helix scaffold for the assembly of active
protein kinases. Proc Natl Acad Sci U S A, 2008. 105(38): p. 14377-82.

27.

Williams, J.C., et al., The 2.35 A crystal structure of the inactivated form of chicken Src:
a dynamic molecule with multiple regulatory interactions. J Mol Biol, 1997. 274(5): p.
757-75.

28.

La Sala, G., et al., HRD Motif as the Central Hub of the Signaling Network for Activation
Loop Autophosphorylation in Abl Kinase. J Chem Theory Comput, 2016. 12(11): p.
5563-5574.

29.

Roskoski, R., Jr., Src protein-tyrosine kinase structure and regulation. Biochem Biophys
Res Commun, 2004. 324(4): p. 1155-64.

30.

Hines, A.C., et al., Bisubstrate analog probes for the insulin receptor protein tyrosine
kinase: molecular yardsticks for analyzing catalytic mechanism and inhibitor design.
Bioorg Chem, 2005. 33(4): p. 285-97.

31.

Banavali, N.K. and B. Roux, Flexibility and charge asymmetry in the activation loop of
Src tyrosine kinases. Proteins, 2009. 74(2): p. 378-89.

32.

Senften, M., et al., Catalytic activity and transformation potential of v-Src require
arginine 385 in the substrate binding pocket. Oncogene, 1995. 10(1): p. 199-203.

33.

Strong, T.C., G. Kaur, and J.H. Thomas, Mutations in the catalytic loop HRD motif alter
the activity and function of Drosophila Src64. PLoS One, 2011. 6(11): p. e28100.

21
John Wiley & Sons

Protein Science

34.

Lock, P., et al., A new method for isolating tyrosine kinase substrates used to identify
fish, an SH3 and PX domain-containing protein, and Src substrate. EMBO J, 1998.
17(15): p. 4346-57.

35.

Boudeau, J., et al., Emerging roles of pseudokinases. Trends Cell Biol, 2006. 16(9): p.
443-52.

36.

Ungureanu, D., et al., The pseudokinase domain of JAK2 is a dual-specificity protein
kinase that negatively regulates cytokine signaling. Nat Struct Mol Biol, 2011. 18(9): p.
971-6.

37.

Taylor, S.S., et al., Pseudokinases from a structural perspective. Biochem Soc Trans,
2013. 41(4): p. 981-6.

38.

Byrne, D.P., D.M. Foulkes, and P.A. Eyers, Pseudokinases: update on their functions and
evaluation as new drug targets. Future Med Chem, 2017. 9(2): p. 245-265.

39.

Huse, M. and J. Kuriyan, The conformational plasticity of protein kinases. Cell, 2002.
109(3): p. 275-82.

40.

Johnson, L.N., M.E. Noble, and D.J. Owen, Active and inactive protein kinases:
structural basis for regulation. Cell, 1996. 85(2): p. 149-58.

41.

Taylor, S.S., et al., PKA: a portrait of protein kinase dynamics. Biochim Biophys Acta,
2004. 1697(1-2): p. 259-69.

42.

McClendon, C.L., et al., Dynamic architecture of a protein kinase. Proc Natl Acad Sci U
S A, 2014. 111(43): p. E4623-31.

43.

Saleh, T., P. Rossi, and C.G. Kalodimos, Atomic view of the energy landscape in the
allosteric regulation of Abl kinase. Nat Struct Mol Biol, 2017.

44.

Tiwari, R.K., et al., Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and

22
John Wiley & Sons

Page 22 of 35

Page 23 of 35

Protein Science

Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors. ChemMedChem,
2017. 12(1): p. 86-99.
45.

Kemble, D.J. and G. Sun, Direct and specific inactivation of protein tyrosine kinases in
the Src and FGFR families by reversible cysteine oxidation. Proc Natl Acad Sci U S A,
2009. 106(13): p. 5070-5.

46.

Huang, K., et al., Identification of N-terminal lobe motifs that determine the kinase
activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine
kinases. J Mol Biol, 2009. 386(4): p. 1066-77.

23
John Wiley & Sons

Protein Science

Figure Legends:
Figure 1. Protein tyrosine phosphorylation by PTKs when expressed in E coli. (A) Protein
phosphorylation by Abl, Csk, FGFR1 and Lck. As described in the Materials and Methods
section, E. coli cells expressing these kinases were collected from overnight cultures and
analyzed by Western Blotting with a monoclonal antibody specific for phosphotyrosine residues.
The same amount of soluble cell lysates for each PTK sample were compared. (B) Protein
tyrosine phosphorylation by Src when it is co-expressed with a protein tyrosine phosphatase in E.
coli. The wtSrc and Src mutants were co-expressed with GroESL in the PTP system. The wtSrc,
kdSrc, and SD-Src were expressed at 370C for 24 hours. The same amount of soluble lysates
were analyzed by Western Blotting with monoclonal antibodies specific for phosphotyrosine and
phosphor-Tyr416, respectively.
Figure 2. Schemes of library construction and proposed screening strategy. A. Construction
of SD-Src and HRD mutant libraries. B. Colony screening. Individual steps are depicted and
labeled, and explained in detail in Materials and Methods.
Figure 3. Representative screening results of His384 mutation library. The His384 mutatant
library was constructed as described in Materials and Methods. Overnight cultures (0.4 l) of
control colonies and unknown colonies were spotted on the nitrocellulose membrane in duplicate
for the dot blotting screen. (A) A representative screening blot of the His384 library in the PTP
system: boxes a1, a2, d1 and d2 have wtSrc-expressing cells as positive controls; boxes b1, b2,
e1 and e2 have kdSrc-expressing cells as negative controls; boxes c1, c2, f1 and f2 have SDSrc-expressing cells as negative controls. Other boxes have colonies expressing random His384
mutants. (B) A representative screening blot of the His384 library in the non-PTP system. The
arrangement of colonies is the same as in Fig. 3A.
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Figure 4. Relative catalytic activity of Src His384 mutants. A. Coomassie blue staining of
selected purified His384 mutant proteins. B. The catalytic activity of His384 mutants toward an
artificial substrate, polyE4Y was determined. The wtSrc activity (210 min-1) is taken as 100%,
and the activity of all other mutants was expressed as a percentage of that of the wtSrc. The
kinase activities of each mutant can be found in the Supplementary Information. The wtSrc is
represented by His as the wtSrc has His at the 384 position, and all other variants are represented
by the residue at this position.
Figure 5. Representative screening results of the Arg385 mutant library. The Arg385 mutant
library was constructed as described in the Materials and Methods section. Colony screening was
performed as described in the legend to Fig. 3. (A) A representative screening blot of the Arg385
library in the PTP system. Boxes a1 and a2 have wtSrc expressing cells as positive controls;
Boxes b1 and b2 have kdSrc-expressing cells as negative controls; Boxes c1 and c2 have S-Src
expressing cells as negative controls. The other boxes have random Arg385 mutant cells. (B) A
representative screening blot of the Arg385 library in the non-PTP system. Colony arrangement
is the same as in Fig. 5A.
Figure 6. Relative catalytic activity of Src Arg385 mutants. A. Coomassie staining of purified
Arg385 mutants fractionated on SDS-PAGE. B. The kinase activity of selected Arg385 mutants
toward an artificial substrate, polyE4Y was determined. The assay was performed as described in
Materials and Methods and the legend to Fig. 4. Detailed information on the kinase mutants is
given in Supplementary Information.
Figure 7. Representative screening results of the Asp386 mutant library. The Asp386 mutant
library was constructed as described in Materials and Methods. (A) A representative screening
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blot of the Asp386 library in the PTP system. Boxes a1, a2, d1 and d2 have wtSrc-expressing
cells as positive controls; Boxes b1, b2, e1 and e2 have kdSrc-expressing cells as negative
controls; boxes c1, c2, f1 and f2 have S-Src-expressing cells as negative controls. Other boxes
have random Asp386 mutant-expressing colonies. (B) A representative screening blot of Asp386
library in the non-PTP system. The colony arrangement is identical to that in Fig. 7A.
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Cui Y. and Sun G. Supplementary Information
Kinase activity determination for His384 mutants. (Complementary to Figure 4)
wtsrc R385T R385K R385V R385N R395A R385S R385L R385G
Assay 1 (min-1)
200.25 62.43 100.15 187.16 182.38 55.66 36.57 75.00 40.02
Assay 2 (min-1)
207.50 79.77 82.78 181.76 197.85 62.78 36.26 80.12 48.14
Assay 3 (min-1)
222.10 51.75 91.51 169.28 176.15 57.59 35.54 70.89 33.18
mean
209.95 64.65 91.48 179.40 185.46 58.68 36.13 75.34 40.45
standard error 6.43
8.16
5.01
5.29
6.45
2.13
0.30
2.67
4.32
Relative activity
100.00
(% of wt)
30.79 43.56 85.43 88.31 27.94 17.20 35.87 19.26
standard error 0.00
3.89
2.39
2.52
3.07
1.01
0.14
1.27
2.06

R385C
155.54
150.71
134.79
147.02
6.27
70.01
2.98

Kinase activity determination for Arg385 mutants. (Complementary to Figure 6)
wtsrc H384F H384S H384V H384L H384I H384G H384Q H384Y H384T
Assay 1 (min-1)
200.25 21.23
9.28 -2.57
1.43
2.34
0.51 34.24 17.08 12.70
Assay 2 (min-1)
207.50 13.18
4.76
3.53
0.94
0.34
0.13 23.21
8.58
8.09
Assay 3 (min-1)
222.10 29.63
2.56
2.67
4.43
0.97
0.45 32.49 13.51 16.91
mean
209.95 21.35
5.53
1.21
2.27
1.22
0.36 29.98 13.06 12.57
standard error 6.43
4.75
1.98
1.91
1.09
0.59
0.12
3.42
2.47
2.55
Relative activity
100.00
(% of wt)
10.17
2.63
0.57
1.08
0.58
0.17 14.28
6.22
5.98
standard error 0.00
2.26
0.94
0.91
0.52
0.28
0.06
1.63
1.17
1.21
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